Friday, December 27, 2024

Element Announces RegNav, its First AI-Powered Platform Promoting Safer and More Reliable Medical Device Development

Related stories

Pollo AI Unveils Game-Changing Video-to-Video Feature

Pollo AI, a leading AI video generator released by...

SKF Enhances Customer Support with AI Tool

SKF Product assistant, a new search assistant for finding...

PFN, Mitsubishi, and IIJ Partner for AI Cloud

Preferred Networks (PFN), Mitsubishi Corporation (MC) and Internet Initiative Japan (IIJ) have on...

KAYTUS NextGen Server: High Performance with Liquid Cooling for AI

KAYTUS, a leading IT infrastructure provider, announced its new...

Zenity Launches AI Security Solution for Microsoft Fabric Skills

Zenity, the leader in securing Agentic AI everywhere, announced...
spot_imgspot_img

Element Materials Technology (Element), a leading global provider of testing, inspection, and certification (TIC) services, announced the launch of Element RegNav (RegNav), its first artificial intelligence (AI)-powered regulatory intelligence platform for medical devices. Initially launched to support FDA regulatory pathways, RegNav will help bring medical innovations to market safely and more reliably for those in need.

RegNav’s proprietary software combines AI with expert guidance to support medical device manufacturers in identifying the regulations, standards, requirements, and testing needed to support the FDA submission process. Currently, bringing a medical device to market is a lengthy procedure with manufacturers facing a complex regulatory environment.

According to insights from BTIG, a global financial services firm, the average 510(k) premarket submission clearance takes approximately 162 days, nearly twice the FDA goal of 90 days. Delays in clearance are commonly caused by the need for multiple submission turnarounds when missing or additional information is required. In turn, manufacturers are experiencing vast losses of time and money.

To address these issues, RegNav has been co-developed with a specialized team of leading regulatory experts, engineers, and data scientists. The expert pool is comprised of ex-notified body regulatory professionals who have sought to ensure that the framework of RegNav is comprehensive and accurate.

Also Read: ONDO Systems & Caspar AI Team up to Deliver Comprehensive Bed-focused care Leveraging the Power of AI

Jo Wetz, CEO of Element, comments: “The end goal for RegNav is simple: to help our customers bring life-enhancing devices to market safely and more efficiently. Speaking to our existing medical device customers we realize there is a real opportunity to alleviate confusion around medical device regulation and standards, and further enhance our role as a trusted partner in their compliance and certification journey.”

Renae Leary, Chief Commercial Officer at Element, shares: “There is an incredible synergy between our new RegNav offering and existing services. Once we identify a regulatory pathway, we can also support customers in the testing and certification process, acting as a true partner for market access. RegNav strips away the complexity to give customers a clear path to compliance.”

Element RegNav is designed for companies both with and without existing regulatory support, offering two key services:

  • RegNav Premium: Most suitable for companies with devices pre- or post-design freeze who are seeking to ensure that they are well-prepared ahead of submission. RegNav Premium provides a comprehensive and reliable compliance plan for a medical device in under two weeks. The compliance plan outlines the FDA pathway, regulations, FDA product codes, and standards that apply to a device and provides a summary of the testing requirements within each applicable standard.
  • RegNav Verify: Most suitable for companies with an existing plan who want confidence that it is comprehensive before submission. RegNav Verify offers a double-checked & expert-backed review of the standards applicable to a medical device and identifies any gaps ahead of submission.

RegNav gives medical device manufacturers increased confidence that they’re testing the right thing using the right methodology.

Source: Businesswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img